Cargando…
Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease
Inflammatory bowel disease (IBD) has stimulated much interest due to its surging incidences and health impacts in the U.S. and worldwide. However, the exact cause of IBD remains incompletely understood, and biomarker is lacking towards early diagnostics and effective therapy assessment. To tackle th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385106/ https://www.ncbi.nlm.nih.gov/pubmed/30691236 http://dx.doi.org/10.3390/molecules24030449 |
_version_ | 1783397129018933248 |
---|---|
author | Lai, Yunjia Xue, Jingchuan Liu, Chih-Wei Gao, Bei Chi, Liang Tu, Pengcheng Lu, Kun Ru, Hongyu |
author_facet | Lai, Yunjia Xue, Jingchuan Liu, Chih-Wei Gao, Bei Chi, Liang Tu, Pengcheng Lu, Kun Ru, Hongyu |
author_sort | Lai, Yunjia |
collection | PubMed |
description | Inflammatory bowel disease (IBD) has stimulated much interest due to its surging incidences and health impacts in the U.S. and worldwide. However, the exact cause of IBD remains incompletely understood, and biomarker is lacking towards early diagnostics and effective therapy assessment. To tackle these, the emerging high-resolution mass spectrometry (HRMS)-based metabolomics shows promise. Here, we conducted a pilot untargeted LC/MS metabolomic profiling in Crohn’s disease, for which serum samples of both active and inactive cases were collected, extracted, and profiled by a state-of-the-art compound identification workflow. Results show a distinct metabolic profile of Crohn’s from control, with most metabolites downregulated. The identified compounds are structurally diverse, pointing to important pathway perturbations ranging from energy metabolism (e.g., β-oxidation of fatty acids) to signaling cascades of lipids (e.g., DHA) and amino acid (e.g., L-tryptophan). Importantly, an integral role of gut microbiota in the pathogenesis of Crohn’s disease is highlighted. Xenobiotics and their biotransformants were widely detected, calling for massive exposomic profiling for future cohort studies as such. This study endorses the analytical capacity of untargeted metabolomics for biomarker development, cohort stratification, and mechanistic interpretation; the findings might be valuable for advancing biomarker research and etiologic inquiry in IBD. |
format | Online Article Text |
id | pubmed-6385106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63851062019-02-23 Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease Lai, Yunjia Xue, Jingchuan Liu, Chih-Wei Gao, Bei Chi, Liang Tu, Pengcheng Lu, Kun Ru, Hongyu Molecules Article Inflammatory bowel disease (IBD) has stimulated much interest due to its surging incidences and health impacts in the U.S. and worldwide. However, the exact cause of IBD remains incompletely understood, and biomarker is lacking towards early diagnostics and effective therapy assessment. To tackle these, the emerging high-resolution mass spectrometry (HRMS)-based metabolomics shows promise. Here, we conducted a pilot untargeted LC/MS metabolomic profiling in Crohn’s disease, for which serum samples of both active and inactive cases were collected, extracted, and profiled by a state-of-the-art compound identification workflow. Results show a distinct metabolic profile of Crohn’s from control, with most metabolites downregulated. The identified compounds are structurally diverse, pointing to important pathway perturbations ranging from energy metabolism (e.g., β-oxidation of fatty acids) to signaling cascades of lipids (e.g., DHA) and amino acid (e.g., L-tryptophan). Importantly, an integral role of gut microbiota in the pathogenesis of Crohn’s disease is highlighted. Xenobiotics and their biotransformants were widely detected, calling for massive exposomic profiling for future cohort studies as such. This study endorses the analytical capacity of untargeted metabolomics for biomarker development, cohort stratification, and mechanistic interpretation; the findings might be valuable for advancing biomarker research and etiologic inquiry in IBD. MDPI 2019-01-27 /pmc/articles/PMC6385106/ /pubmed/30691236 http://dx.doi.org/10.3390/molecules24030449 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lai, Yunjia Xue, Jingchuan Liu, Chih-Wei Gao, Bei Chi, Liang Tu, Pengcheng Lu, Kun Ru, Hongyu Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease |
title | Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease |
title_full | Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease |
title_fullStr | Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease |
title_full_unstemmed | Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease |
title_short | Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s Disease |
title_sort | serum metabolomics identifies altered bioenergetics, signaling cascades in parallel with exposome markers in crohn’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385106/ https://www.ncbi.nlm.nih.gov/pubmed/30691236 http://dx.doi.org/10.3390/molecules24030449 |
work_keys_str_mv | AT laiyunjia serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease AT xuejingchuan serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease AT liuchihwei serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease AT gaobei serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease AT chiliang serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease AT tupengcheng serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease AT lukun serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease AT ruhongyu serummetabolomicsidentifiesalteredbioenergeticssignalingcascadesinparallelwithexposomemarkersincrohnsdisease |